• Home
  • Stock
  • Fredun Pharmaceuticals Fundamental Analysis
  • Fredun Pharmaceuticals Fundamental Analysis

Fredun Pharmaceuticals fundamental analysis

FREDUN

HealthcareSmall

1917.45

32.50 (1.72%)
Last updated on 4 Dec, 2025 | 14:19 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Fredun Pharmaceuticals Fundamentals

P/E Ratio

45.09

P/B Ratio

5.66

Div. Yield

0.04

Sector P/E

36.44

Sector P/B

0.91

Sec. Div. Yield

0.56

  • Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 45.09, compared to the sector average of 36.44. Its P/B Ratio stands at 5.66, while the sector’s is 0.91. In terms of returns, the stock offers a Dividend Yield of 0.04%, which is than the sector’s 0.56%.

Fredun Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Average

  • Management

    Good

  • On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.